89.86
1.02%
0.91
시간 외 거래:
89.86
전일 마감가:
$88.95
열려 있는:
$89.27
하루 거래량:
3.61M
Relative Volume:
0.66
시가총액:
$132.44B
수익:
$15.91B
순이익/손실:
$1.79B
주가수익비율:
109.59
EPS:
0.82
순현금흐름:
$1.89B
1주 성능:
-0.66%
1개월 성능:
-0.16%
6개월 성능:
+15.64%
1년 성능:
+60.75%
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
89.86 | 132.44B | 15.91B | 1.79B | 1.89B | 1.21 |
ABT
Abbott Laboratories
|
114.31 | 198.27B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
366.49 | 139.71B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
81.40 | 104.38B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
2024-05-30 | 개시 | Goldman | Buy |
2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
2023-07-19 | 개시 | Robert W. Baird | Outperform |
2023-06-30 | 개시 | CL King | Buy |
2023-05-30 | 재개 | Morgan Stanley | Overweight |
2023-03-29 | 개시 | UBS | Buy |
2022-12-22 | 개시 | Mizuho | Neutral |
2022-12-20 | 재개 | Citigroup | Buy |
2022-10-18 | 개시 | Barclays | Overweight |
2022-10-12 | 개시 | Jefferies | Buy |
2022-07-06 | 개시 | Wolfe Research | Outperform |
2022-05-27 | 업그레이드 | Needham | Hold → Buy |
2022-04-13 | 재개 | Truist | Buy |
2022-03-02 | 재개 | BofA Securities | Buy |
2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
2021-05-25 | 개시 | Barclays | Overweight |
2021-04-15 | 개시 | Atlantic Equities | Overweight |
2020-09-17 | 개시 | Truist | Buy |
2020-09-11 | 개시 | Wolfe Research | Peer Perform |
2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
2020-03-05 | 개시 | Citigroup | Buy |
2020-02-13 | 개시 | Goldman | Neutral |
2020-02-06 | 재개 | BTIG Research | Buy |
2019-12-30 | 재확인 | Cowen | Outperform |
2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
2019-09-05 | 재개 | JP Morgan | Overweight |
2019-09-03 | 재개 | Barclays | Overweight |
2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
2018-11-28 | 개시 | UBS | Buy |
2018-10-16 | 개시 | Barclays | Overweight |
2018-10-02 | 재확인 | Morgan Stanley | Overweight |
2018-09-07 | 재확인 | Needham | Strong Buy |
2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
2018-07-06 | 재확인 | Needham | Strong Buy |
2018-06-27 | 개시 | Bernstein | Outperform |
2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific (BSX) Rises Higher Than Market: Key Facts - Yahoo Finance
Boston Scientific may sell endosurgery unit stake - Reuters
Boston Scientific Corp. stock rises Friday, still underperforms market - MarketWatch
Truist maintains Buy on Boston Scientific with $110 target - Investing.com
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries - Benzinga
Should You Be Adding Boston Scientific (NYSE:BSX) To Your Watchlist Today? - Yahoo Finance
Principal Financial Group Inc. Buys 111,724 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pain Management Devices Market May See a Big Move | Medtronic, Boston Scientific, LivaNova - openPR
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy - Yahoo Finance
Boston Scientific updates instructions for cryoablation catheters after reported deaths - Mass Device
Boston Scientific price target raised to $110 from $100 at Truist - Yahoo Finance
Boston Scientific updates cryoablation catheter instructions after 4 death reports - Yahoo Finance
FDA classifies recall of Boston Scientific catheters as 'most serious' - Reuters
FDA classifies recall of Boston Scientific catheters as 'most serious' By Reuters - Investing.com
Boston Scientific shares target increased, holds Buy on growth prospects - Investing.com
Boston Scientific (NYSE:BSX) Price Target Raised to $110.00 - MarketBeat
Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific recalls Accolade pacemakers tied to 2 deaths - Yahoo Finance
Boston Scientific warns on potential need to replace Accolade pacemaker devices early - Mass Device
Boston Scientific has a new Peripheral Interventions leader in EMEA - Mass Device
Sanctuary Advisors LLC Sells 6,069 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Wilmington Savings Fund Society FSB Makes New Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 121% gain - Yahoo Finance
Short Interest in Boston Scientific Co. (NYSE:BSX) Grows By 11.2% - MarketBeat
Jim Cramer on Boston Scientific Corporation (BSX): ‘A Superior Company’ - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Zacks Investment Research
Oddo BHF Asset Management Sas Buys New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Franklin Resources Inc. - MarketBeat
Boston Scientific best idea at TD Cowen, lifts PT by $10 - Investing.com
Boston Scientific shares target lifted, buy rating on robust performance - Investing.com
Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes - Yahoo Finance
Boston Scientific Co. (NYSE:BSX) Shares Sold by Toronto Dominion Bank - MarketBeat
Teachers Retirement System of The State of Kentucky Sells 150,603 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
TCW Group Inc. Sells 147,999 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace - Quantisnow
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace – Company Announcement - Financial Times
Brown Financial Advisors Has $1.04 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Vestcor Inc Has $3.38 Million Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific Corporation (NYSE:BSX) Could Be Worth Watching - Yahoo Finance
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) Stock Holdings Decreased by Nomura Asset Management Co. Ltd. - MarketBeat
Boston Scientific Co. (NYSE:BSX) Position Increased by Zacks Investment Management - MarketBeat
National Bank of Canada FI Increases Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
United Services Automobile Association Sells 7,295 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Worldquant Millennium Advisors LLC Makes New $9.04 Million Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):